Ekim Ekinci

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 4

Top Topics

Prognostic Factors

Ejection Fraction

Positive Breast Cancer

Replacement Therapy

Top Venues

The Annals of pharmacotherapy

Bone marrow transplantation

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Bharati Bhardwaja, Shilpa Klocke, Ekim Ekinci, Adam Jackson, Scott Kono, Kari L Olson
Switching from Biologic to Biosimilar Products: Insight from an Integrated Health Care System. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2021)
Rutugandha Paranjpe, Dima Basatneh, Gabriel Tao, Carmine De Angelis, Sobia Noormohammed, Ekim Ekinci, Susan Abughosh, Romi Ghose, Meghana V Trivedi
Neratinib in HER2-Positive Breast Cancer Patients. The Annals of pharmacotherapy 53 (6) (2019)
Akash Mukherjee, Ekim Ekinci, Audrey Scholoff, Gloria Obi, Ngoc Vu, George Carrum, Rammurti T Kamble
Voriconazole photosensitivity causes apparent graft-versus-host disease exacerbation. Bone marrow transplantation 54 (2) (2018)
Kaitlin Rascon, Goran Flajc, Carmine De Angelis, Xinli Liu, Meghana V Trivedi, Ekim Ekinci
Ribociclib in HR+/HER2- Advanced or Metastatic Breast Cancer Patients. The Annals of pharmacotherapy 53 (5) (2018)